Table 3: Laboratory data change of renal and hepatic functions markers in ESRD and chronic HD patients treated with AG.

 

Before

After

3rd month

6th month

One year

Cr (mg/dL)

1 p

7.0 ± 2.2

8.2 ± 2.3

8.2 ± 2.0

8.0 ± 2.3

 

2 p

7.3 ± 2.0

7.8 ± 1.5

8.1 ± 1.7

7.8 ± 1.7

BUN (mg/dL)

1 p

42 ± 16

54 ± 23

53 ± 15

52 ± 16

 

2 p

39 ± 11

56 ± 12

59 ± 10

55 ± 15

UA (mg/dL)

1 p

5.9 ± 1.6

6.8 ± 1.8

6.7 ± 1.9

6.6 ± 1.4

 

2 p

5.3 ± 1.0

5.6 ± 0.7

5.8 ± 0.9

5.7 ± 1.1

c-Ca (mg/dL)

1 p

9.0 ± 0.6

9.3 ± 0.1

9.0 ± 0.3

9.6 ± 0.9

 

2 p

9.3 ± 1.0

9.1 ± 0.9

9.0 ± 0.5

9.1 ± 0.6

P (mg/dL)

1 p

4.2 ± 2.2

4.0 ± 1.2

4.1 ± 1.1

4.3 ± 0.9

 

2 p

4.8 ± 2.1

4.6 ± 1.2

5.1 ± 1.1

4.6 ± 1.4

AST (IU/L)

1 p

11 ± 1

10 ± 2

10 ± 2

10 ± 1

 

2 p

17 ± 6*

20 ± 6*

18 ± 3*

17 ± 3*

ALT (IU/L)

1 p

6 ± 2

7 ± 3

6 ± 2

5 ± 2

 

2 p

10 ± 2*

11 ± 1*

11 ± 2*

10 ± 3*

The data are expressed as mean ± standard deviation; *: P < 0.05 compared between the one powder and the two powders groups

Cr: Creatinine; BUN: Blood urea nitrogen; UA: Urea acid; c-Ca: corrected Calcium; P: Phosphate; ASL: Aspartate aminotransferase; ALT: Alanine aminotransferase; 1 p: One powder AG; 2 p: Two powders AG